1. 136 NOVA primary results randomised controlled study of natalizumab Q6W versus continued Q4W treatment for MS. Issue 9 (12th August 2022) Authors: Foley, John; Defer, Gilles; Ryerson, Lana Zhovtis; Cohen, Jeffrey; Arnold, Douglas; Butzkueven, Helmut; Cutter, Gary; Giovannoni, Gavin; Killestein, Joep Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 93:Issue 9(2022) Page Start: e2 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. BEST-MS: A prospective head-to-head comparative study of natalizumab and fingolimod in active relapsing MS. (September 2021) Authors: Cohen, Mikael; Mondot, Lydiane; Bucciarelli, Florence; Pignolet, Béatrice; Laplaud, David-Axel; Wiertlewski, Sandrine; Brochet, Bruno; Ruet, Aurélie; Defer, Gilles; Derache, Nathalie; Vermersch, Patrick; Zephir, Hélène; Debouverie, Marc; Mathey, Guillaume; Berger, Eric; Cappé, Chrystelle; Labauge... Journal: Multiple sclerosis Issue: Volume 27:Number 10(2021) Page Start: 1556 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. CD62L test at 2 years of natalizumab predicts progressive multifocal leukoencephalopathy. (6th December 2016) Authors: Pignolet, Béatrice; Schwab, Nicholas; Schneider-Hohendorf, Tilman; Bucciarelli, Florence; Biotti, Damien; Averseng-Peaureaux, Delphine; Outteryck, Olivier; Ongagna, Jean-Claude; de Sèze, Jérôme; Brochet, Bruno; Ouallet, Jean-Christophe; Debouverie, Marc; Pittion, Sophie; Defer, Gilles; Derache, N... Journal: Neurology Issue: Volume 87:Number 23(2016) Page Start: 2491 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. CD62L test at 2 years of natalizumab predicts progressive multifocal leukoencephalopathy. (6th December 2016) Authors: Pignolet, Béatrice; Schwab, Nicholas; Schneider-Hohendorf, Tilman; Bucciarelli, Florence; Biotti, Damien; Averseng-Peaureaux, Delphine; Outteryck, Olivier; Ongagna, Jean-Claude; de Sèze, Jérôme; Brochet, Bruno; Ouallet, Jean-Christophe; Debouverie, Marc; Pittion, Sophie; Defer, Gilles; Derache, N... Journal: Neurology Issue: Volume 87:Number 23(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Cluster headache-like attack as an opening symptom of a unilateral infarction of the cervical cord: Persistent anaesthesia and dysaesthesia to cold stimuli. Issue 3 (1st March 1999) Authors: de la Sayette, Vincent; Schaeffer, Stéphane; Coskun, Oguzhan; Leproux, François; Defer, Gilles Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 66:Issue 3(1999) Page Start: 397 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Comparative effectiveness of teriflunomide vs dimethyl fumarate in multiple sclerosis. (13th August 2019) Authors: Laplaud, David-Axel; Casey, Romain; Barbin, Laetitia; Debouverie, Marc; De Sèze, Jérôme; Brassat, David; Wiertlewski, Sandrine; Brochet, Bruno; Pelletier, Jean; Vermersch, Patrick; Edan, Gilles; Lebrun-Frenay, Christine; Clavelou, Pierre; Thouvenot, Eric; Camdessanché, Jean-Philippe; Tourbah, Aym... Journal: Neurology Issue: Volume 93:Number 7(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Comparative efficacy of fingolimod vs natalizumab: A French multicenter observational study. (23rd February 2016) Authors: Barbin, Laetitia; Rousseau, Chloe; Jousset, Natacha; Casey, Romain; Debouverie, Marc; Vukusic, Sandra; De Sèze, Jerome; Brassat, David; Wiertlewski, Sandrine; Brochet, Bruno; Pelletier, Jean; Vermersch, Patrick; Edan, Gilles; Lebrun-Frenay, Christine; Clavelou, Pierre; Thouvenot, Eric; Camdessanc... Journal: Neurology Issue: Volume 86:Number 8(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Comparison of switching to 6-week dosing of natalizumab versus continuing with 4-week dosing in patients with relapsing-remitting multiple sclerosis (NOVA): a randomised, controlled, open-label, phase 3b trial. Issue 7 (July 2022) Authors: Foley, John F; Defer, Gilles; Ryerson, Lana Zhovtis; Cohen, Jeffrey A; Arnold, Douglas L; Butzkueven, Helmut; Cutter, Gary; Giovannoni, Gavin; Killestein, Joep; Wiendl, Heinz; Smirnakis, Karen; Xiao, Shan; Kong, George; Kuhelj, Robert; Campbell, Nolan; van der Walt, Anneke; Dwyer, Christopher; Bu... Journal: Lancet neurology Issue: Volume 21:Issue 7(2022) Page Start: 608 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Descriptive analysis of the French NS-Park registry: Towards a nation-wide Parkinson's disease cohort?. (July 2019) Authors: Mariani, Louise-Laure; Doulazmi, Mohamed; Chaigneau, Véronique; Brefel-Courbon, Christine; Carrière, Nicolas; Danaila, Teodor; Defebvre, Luc; Defer, Gilles; Dellapina, Estelle; Doé de Maindreville, Anne; Geny, Christian; Maltête, David; Meissner, Wassilios G.; Rascol, Olivier; Thobois, Stéphane; ... Journal: Parkinsonism & related disorders Issue: Volume 64(2019) Page Start: 226 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Determinants of therapeutic lag in multiple sclerosis. (October 2021) Authors: Roos, Izanne; Leray, Emmanuelle; Frascoli, Federico; Casey, Romain; Brown, J William L; Horakova, Dana; Havrdova, Eva Kubala; Debouverie, Marc; Trojano, Maria; Patti, Francesco; Izquierdo, Guillermo; Eichau, Sara; Edan, Gilles; Prat, Alexandre; Girard, Marc; Duquette, Pierre; Onofrj, Marco; Lugar... Journal: Multiple sclerosis Issue: Volume 27:Number 12(2021) Page Start: 1838 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗